GT
WST icon

Greenleaf Trust’s West Pharmaceutical WST Stock Holding History

Greenleaf Trust’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$303K Buy
843
+33
+4% +$10.1K ﹤0.01% 693
2026
Q1 		$203K Sell
810
-44
-5% -$10.9K ﹤0.01% 779
2025
Q4 		$235K Buy
854
+20
+2% +$5.47K ﹤0.01% 735
2025
Q3 		$219K Buy
+834
New +$203K ﹤0.01% 753
2025
Q1 		– Sell
-1,210
Closed -$396K – 839
2024
Q4 		$396K Buy
1,210
+156
+15% +$49.1K ﹤0.01% 567
2024
Q3 		$316K Sell
1,054
-22
-2% -$6.74K ﹤0.01% 647
2024
Q2 		$354K Sell
1,076
-84
-7% -$29.7K ﹤0.01% 568
2024
Q1 		$459K Buy
1,160
+7
+0.6% +$2.59K ﹤0.01% 497
2023
Q4 		$406K Sell
1,153
-386
-25% -$137K ﹤0.01% 521
2023
Q3 		$577K Sell
1,539
-32
-2% -$12.4K 0.01% 393
2023
Q2 		$601K Buy
1,571
+15
+1% +$5.36K 0.01% 409
2023
Q1 		$539K Buy
1,556
+307
+25% +$89.7K 0.01% 430
2022
Q4 		$294K Buy
1,249
+108
+9% +$25.6K ﹤0.01% 588
2022
Q3 		$281K Sell
1,141
-133
-10% -$40.5K ﹤0.01% 563
2022
Q2 		$385K Sell
1,274
-1
-0.1% -$325 0.01% 482
2022
Q1 		$524K Sell
1,275
-1
-0.1% -$391 0.01% 403
2021
Q4 		$598K Buy
1,276
+5
+0.4% +$2.15K 0.01% 369
2021
Q3 		$540K Buy
1,271
+61
+5% +$25.7K 0.01% 366
2021
Q2 		$435K Sell
1,210
-782
-39% -$258K 0.01% 439
2021
Q1 		$561K Buy
1,992
+128
+7% +$36.6K 0.01% 344
2020
Q4 		$528K Buy
1,864
+14
+0.8% +$3.93K 0.01% 319
2020
Q3 		$509K Buy
1,850
+873
+89% +$231K 0.01% 280
2020
Q2 		$222K Buy
+977
New +$192K ﹤0.01% 481
2018
Q2 		– Sell
-349
Closed -$31K – 589
2018
Q1 		$31K Hold
349
– – ﹤0.01% 500
2017
Q4 		$34K Hold
349
– – ﹤0.01% 520
2017
Q3 		$34K Buy
+349
New +$31.6K ﹤0.01% 487

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Greenleaf Trust's WST Position: Q2 2026 in Review

Greenleaf Trust increased its West Pharmaceutical (WST) stake by 4.1% in Q2 2026, buying an estimated $10.1K and bringing the position to 843 shares worth $303K. The position accounts for ﹤0.01% of the portfolio, ranked #693.

Greenleaf Trust first reported a position in WST in Q3 2017 and has held it in 26 quarters since. The position peaked at $601K in Q2 2023. 831 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Greenleaf Trust held 843 shares of West Pharmaceutical worth $303K as of Q2 2026.
  • Greenleaf Trust bought 33 West Pharmaceutical shares in Q2 2026, an estimated $10.1K.
  • West Pharmaceutical made up ﹤0.01% of Greenleaf Trust's portfolio in Q2 2026, its #693 holding.
  • Greenleaf Trust first reported a position in West Pharmaceutical in Q3 2017 and has held it in 26 quarters since.
  • Greenleaf Trust's West Pharmaceutical position peaked at $601K in Q2 2023.
  • 831 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Greenleaf Trust's 13F filing for Q2 2026, filed 21 Jul 2026.